Research ArticleArticle
Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RA
Walter P. Maksymowych, Oliver FitzGerald, Mikkel Østergaard, Joanne Homik, Désirée van der Heijde, Robert G. Lambert, Ori Elkayam, Sofia Ramiro, J. Carter Thorne, Maggie J. Larché, Gianfranco Ferraccioli, Marina Backhaus, Gerd R. Burmester, Gilles Boire, Bernard Combe, Thierry Schaeverbeke, Alain Saraux, Maxime Dougados, Maurizio Rossini, Marcello Govoni, Luigi Sinigaglia, Alain Cantagrel, Cheryl Barnabe, Clifton O. Bingham III, Paul P. Tak, Dirkjan van Schaardenburg, Hilde Berner Hammer, Joel Paschke, Rana Dadashova, Edna Hutchings, Alexandre Sepriano and Robert Landewé
The Journal of Rheumatology September 2019, jrheum.190302; DOI: https://doi.org/10.3899/jrheum.190302
Walter P. Maksymowych
From the Departments of Medicine and Radiology, University of Alberta; CaRE Arthritis Ltd., Edmonton, Alberta; The Arthritis Program Research Group, Newmarket, Ontario; Divisions of Rheumatology and Clinical Immunology and Allergy, McMaster University, Hamilton, Ontario; Departments of Medicine and Community Health Services, Cumming School of Medicine, University of Calgary, Calgary, Alberta; Rheumatology Department, CIUSSS de l’Estrie-CHUS, Université de Sherbrooke, Sherbrooke, Quebec, Canada; Department of Rheumatology, St. Vincent’s University Hospital, Dublin, Ireland; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet - Glostrup, University of Copenhagen, Copenhagen, Denmark; Department of Rheumatology, Leiden University Medical Center, Leiden; Zuyderland Medical Center, Heerlen; Academic Medical Center/University of Amsterdam, Amsterdam University Medical Center, Amsterdam, the Netherlands; Department of Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Divisions of Rheumatology and Internal Medicine, Catholic University of the Sacred Heart, Rome; Department of Rheumatology, Università di Verona, Verona; St. Anna Hospital, Ferrara (loc. Cona); Department of Rheumatology, Istituto Ortopedico Gaetano Pini, Milan, Italy; Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany; Departement de rhumatologie, Université de Montpellier, CHU Montpellier, Montpellier; Service de rhumatologie, CHU Brest, and Lymphocyte B et Autoimmunité (LBAI), U1227, Université de Brest, INSERM, F-29200 Brest; Paris Descartes University, Rheumatology Department, Cochin Hospital, AP-HP, INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris; Centre de Rhumatologie, Hôpital Pierre Paul Riquet – Purpan, CHU de Toulouse, Toulouse; Service de Rhumatologie, CHU Bordeaux Pellegrin, Bordeaux, France; Divisions of Rheumatology and Allergy and Clinical Immunology, Johns Hopkins University, Baltimore, Maryland, USA; Amsterdam Rheumatology and Immunology Center, locations Reade and Amsterdam, University Medical Center, Amsterdam, the Netherlands; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. This is an investigator-initiated study aimed at the clinical validation of biomarkers, which has been supported by unrestricted funding from AbbVie Corp. AbbVie had no role in the design, execution, or analysis of this study and had no role in the drafting of the manuscript. W.P. Maksymowych is Chief Medical Officer of the International Project Management Group, CaRE Arthritis Ltd. W.P. Maksymowych, FRCP(C), Professor of Medicine, University of Alberta, and Chief Medical Officer, CaRE Arthritis Ltd.; O. FitzGerald, MD, Newman Clinical Research Professor, Department of Rheumatology, St. Vincent’s University Hospital; M. Østergaard, DMSc, Professor of Rheumatology, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet - Glostrup, University of Copenhagen; J. Homik, FRCP(C), Professor of Medicine, University of Alberta; D. van der Heijde, MD, Professor of Rheumatology, Department of Rheumatology, Leiden University Medical Center; R.G. Lambert, FRCP(C), Department of Radiology, University of Alberta; O. Elkayam, MD, Department of Rheumatology, Tel Aviv Sourasky Medical Center; S. Ramiro, MD, PhD, Department of Rheumatology, Leiden University Medical Center, and Zuyderland Medical Center; J.C. Thorne, FRCP(C), The Arthritis Program Research Group; M.J. Larché, MBChB, PhD, Divisions of Rheumatology and Clinical Immunology and Allergy, McMaster University; G. Ferraccioli, MD, Divisions of Rheumatology and Internal Medicine, Catholic University of the Sacred Heart; M. Backhaus, MD, Department of Rheumatology and Clinical Immunology, Charité University Hospital; G.R. Burmester, MD, Professor of Medicine, Department of Rheumatology and Clinical Immunology, Charité University Hospital; G. Boire, FRCP(C), Professor of Medicine, Rheumatology Department, CIUSSS de l’Estrie-CHUS, Université de Sherbrooke; B. Combe, MD, PhD, Professor of Rheumatology, Departement de rhumatologie, Université de Montpellier, CHU Montpellier; T. Schaeverbeke, MD, Service de Rhumatologie, CHU Bordeaux Pellegrin; A. Saraux, MD, Service de rhumatologie, CHU Brest, and LBAI, U1227, Université Brest, INSERM, F-29200 Brest; M. Dougados, MD, Professor of Medicine, Paris Descartes University, Rheumatology Department, Cochin Hospital, AP-HP, INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité; M. Rossini, MD, Department of Rheumatology, Università di Verona; M. Govoni, MD, Associate Professor of Rheumatology, St. Anna Hospital; L. Sinigaglia, MD, Department of Rheumatology, Istituto Ortopedico Gaetano Pini; A. Cantagrel, MD, Centre de Rhumatologie, Hôpital Pierre Paul Riquet – Purpan, CHU de Toulouse; C. Barnabe, MD, Associate Professor, Departments of Medicine and Community Health Services, Cumming School of Medicine, University of Calgary; C.O. Bingham III, MD, Divisions of Rheumatology and Allergy and Clinical Immunology, Johns Hopkins University; P.P. Tak, MD, Professor of Medicine, Academic Medical Center, Amsterdam University Medical Center; D. van Schaardenburg, MD, Professor of Medicine, Amsterdam Rheumatology and Immunology Center, locations Reade and Amsterdam, University Medical Center; H. Berner Hammer, MD, Department of Rheumatology, Diakonhjemmet Hospital; J. Paschke, BSc, CaRE Arthritis Ltd.; R. Dadashova, MD, Project Manager, CaRE Arthritis Ltd.; E. Hutchings, RN, CaRE Arthritis Ltd.; A. Sepriano, MD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, Academic Medical Center, University of Amsterdam, and Zuyderland Medical Center. Address correspondence to Dr. W.P. Maksymowych, CaRE Arthritis Ltd., #210, 316 Windemere Road NW, Edmonton, Alberta T6W 2Z8, Canada. E-mail: walter.maksymowych@carearthritis.com. Accepted for publication August 12, 2019.
Oliver FitzGerald
Mikkel Østergaard
Joanne Homik
Désirée van der Heijde
Robert G. Lambert
Ori Elkayam
Sofia Ramiro
J. Carter Thorne
Maggie J. Larché
Gianfranco Ferraccioli
Marina Backhaus
Gerd R. Burmester
Gilles Boire
Bernard Combe
Thierry Schaeverbeke
Alain Saraux
Maxime Dougados
Maurizio Rossini
Marcello Govoni
Luigi Sinigaglia
Alain Cantagrel
Cheryl Barnabe
Clifton O. Bingham III
Paul P. Tak
Dirkjan van Schaardenburg
Hilde Berner Hammer
Joel Paschke
Rana Dadashova
Edna Hutchings
Alexandre Sepriano
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RA
Walter P. Maksymowych, Oliver FitzGerald, Mikkel Østergaard, Joanne Homik, Désirée van der Heijde, Robert G. Lambert, Ori Elkayam, Sofia Ramiro, J. Carter Thorne, Maggie J. Larché, Gianfranco Ferraccioli, Marina Backhaus, Gerd R. Burmester, Gilles Boire, Bernard Combe, Thierry Schaeverbeke, Alain Saraux, Maxime Dougados, Maurizio Rossini, Marcello Govoni, Luigi Sinigaglia, Alain Cantagrel, Cheryl Barnabe, Clifton O. Bingham , Paul P. Tak, Dirkjan van Schaardenburg, Hilde Berner Hammer, Joel Paschke, Rana Dadashova, Edna Hutchings, Alexandre Sepriano, Robert Landewé
The Journal of Rheumatology Sep 2019, jrheum.190302; DOI: 10.3899/jrheum.190302
Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RA
Walter P. Maksymowych, Oliver FitzGerald, Mikkel Østergaard, Joanne Homik, Désirée van der Heijde, Robert G. Lambert, Ori Elkayam, Sofia Ramiro, J. Carter Thorne, Maggie J. Larché, Gianfranco Ferraccioli, Marina Backhaus, Gerd R. Burmester, Gilles Boire, Bernard Combe, Thierry Schaeverbeke, Alain Saraux, Maxime Dougados, Maurizio Rossini, Marcello Govoni, Luigi Sinigaglia, Alain Cantagrel, Cheryl Barnabe, Clifton O. Bingham , Paul P. Tak, Dirkjan van Schaardenburg, Hilde Berner Hammer, Joel Paschke, Rana Dadashova, Edna Hutchings, Alexandre Sepriano, Robert Landewé
The Journal of Rheumatology Sep 2019, jrheum.190302; DOI: 10.3899/jrheum.190302